1. Isolation and characterization of cytotoxic and insulin-releasing components from the venom of the black-necked spitting cobra Naja nigricollis (Elapidae)
- Author
-
Nicholas R. Casewell, Libia Sanz, J.M. Conlon, Vishal Musale, Jérôme Leprince, Juan J. Calvete, Samir Attoub, and Ministerio de Ciencia, Innovación y Universidades (España)
- Subjects
Naja ,Cytotoxicity ,qu_68 ,Peptide ,Venom ,Toxicology ,qy_25 ,Insulinotropic activity ,Three-finger toxins ,lcsh:RA1190-1270 ,Phospholipase A2 ,Cytotoxic T cell ,lcsh:Toxicology. Poisons ,qw_630 ,chemistry.chemical_classification ,biology ,Chemistry ,Venomics at the crossroads between ecological and clinical toxinology, Edited by: Dr. Juan Calvete, Dr.Jose Maria Gutiérrez and Dr. Cleópatra A.S. Caldeira ,biology.organism_classification ,Molecular biology ,Cell culture ,Spitting cobra ,Naja nigricollis ,wd_410 - Abstract
8 páginas, 4 figuras, 1 tabla, Four peptides with cytotoxic activity against BRIN-BD11 rat clonal β-cells were purified from the venom of the black-necked spitting cobra Naja nigricollis using reversed-phase HPLC. The peptides were identified as members of the three-finger superfamily of snake toxins by ESI-MS/MS sequencing of tryptic peptides. The most potent peptide (cytotoxin-1N) showed strong cytotoxic activity against three human tumor-derived cell lines (LC50 = 0.8 ± 0.2 μM for A549 non-small cell lung adenocarcinoma cells; LC50 = 7 ± 1 μM for MDA-MB-231 breast adenocarcinoma cells; and LC50 = 9 ± 1 μM for HT-29 colorectal adenocarcinoma cells). However, all the peptides were to varying degrees cytotoxic against HUVEC human umbilical vein endothelial cells (LC50 in the range 2-22 μM) and cytotoxin-2N was moderately hemolytic (LC50 = 45 ± 3 μM against mouse erythrocytes). The lack of differential activity against cells derived from non-neoplastic tissue limits their potential for development into anti-cancer agents. In addition, two proteins in the venom, identified as isoforms of phospholipase A2, effectively stimulated insulin release from BRIN-BD11 cells (an approximately 6-fold increase in rate compared with 5.6 mM glucose alone) at a concentration (1 μM) that was not cytotoxic to the cells suggesting possible application in therapy for Type 2 diabetes., This work was partly supported by the Ministerio de Ciencia, Innovacion � y Universidades, Madrid, Spain (grant number BFU 2017- 89103-P) to JJC.
- Published
- 2020